T. Glauser

Publications248
h-index61
Citations17,774
Highly Influential Citations757
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • S. Berkovic
  • 758 Publications, 54,655 Citations
  • I. Scheffer
  • 568 Publications, 43,245 Citations
  • E. Perucca
  • 601 Publications, 28,437 Citations
  • S. Shinnar
  • 249 Publications, 22,279 Citations
  • Publications
  • Influence
Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009
The International League Against Epilepsy (ILAE) Commission on Classification and Terminology has revised concepts, terminology, and approaches for classifying seizures and forms of epilepsy.… Expand
  • 3,324
  • 180
  • PDF
Guidelines for the Evaluation and Management of Status Epilepticus
Status epilepticus (SE) treatment strategies vary substantially from one institution to another due to the lack of data to support one treatment over another. To provide guidance for the acute… Expand
  • 889
  • 62
  • PDF
ILAE Treatment Guidelines: Evidence‐based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes
Summary:  Purpose: To assess which antiepileptic medications (AEDs) have the best evidence for long‐term efficacy or effectiveness as initial monotherapy for patients with newly diagnosed or… Expand
  • 659
  • 37
  • PDF
Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies
Although no randomized studies have demonstrated a positive impact of therapeutic drug monitoring (TDM) on clinical outcome in epilepsy, evidence from nonrandomized studies and everyday clinical… Expand
  • 721
  • 34
  • PDF
Rufinamide for generalized seizures associated with Lennox–Gastaut syndrome
Background: Lennox–Gastaut syndrome is a catastrophic pediatric epilepsy syndrome characterized by multiple types of treatment-resistant seizures and high rates of seizure-related injury. Current… Expand
  • 266
  • 28
Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
The purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long‐term efficacy or effectiveness for antiepileptic… Expand
  • 453
  • 23
  • PDF
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
BACKGROUND Childhood absence epilepsy, the most common pediatric epilepsy syndrome, is usually treated with ethosuximide, valproic acid, or lamotrigine. The most efficacious and tolerable initial… Expand
  • 330
  • 20
  • PDF
Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society
CONTEXT: The optimal pharmacologic treatment for early convulsive status epilepticus is unclear. OBJECTIVE: To analyze efficacy, tolerability and safety data for anticonvulsant treatment of children… Expand
  • 414
  • 19
  • PDF
Brain magnetic resonance imaging abnormalities after the Norwood procedure using regional cerebral perfusion.
OBJECTIVES Neurologic deficits are common after the Norwood procedure for hypoplastic left heart syndrome. Because of the association of deep hypothermic circulatory arrest with adverse neurologic… Expand
  • 155
  • 14
  • PDF
Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures
Objective: To evaluate the efficacy and tolerability of levetiracetam (LEV) as adjunctive therapy in children (4 to 16 years) with treatment-resistant partial-onset seizures. Methods: This… Expand
  • 232
  • 9
  • PDF